Linezolid Injection, Solution
Product Images NDC 0781-3433

4 FDA label images from Sandoz Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Linezolid (NDC 0781-3433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

200mglabelforswitzerland (200mgswitzerland)

200mglabelforswitzerland (200mgswitzerland)
Linezolid Injection 200 mg/100 mL intravenous solution label by Sandoz Inc. The label includes the NDC number 0781-3431-46 and states it is a single-dose, sterile, nonpyrogenic container for prescription use. It lists ingredients per mL, storage instructions (20° to 25°C, protect from light, do not freeze), and manufacturer's details (manufactured in Switzerland for Sandoz, product of India). Contains barcode and safety warnings.*
FDA Label Image

Label (600mgswitzerland)

Label (600mgswitzerland)
Label for Linezolid Injection 600 mg/300 mL intravenous solution by Sandoz Inc. The label lists ingredients per mL including Linezolid 2 mg, dextrose, sodium citrate, and citric acid, with pH adjusted to 4.8. It includes storage instructions to keep between 20° to 25°C, protect from light, and not freeze. The product is sterile, single-dose, manufactured in Switzerland, and distributed by Sandoz.*
FDA Label Image

Structure (Image 01)

Structure (Image 01)
Chemical structure of linezolid showing its molecular arrangement including a fluorophenyl group, morpholine ring, and oxazolidinone core with an acetamide substituent.*
FDA Label Image

Figure1 (Image 02)

Figure1 (Image 02)
A line graph showing Linezolid plasma concentration (µg/mL) over time (hours) after a 600 mg oral dose every 12 hours. The y-axis represents Linezolid plasma concentration, and the x-axis shows time after dose, displaying a peak followed by a gradual decline over 12 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.